Literature DB >> 15780117

Predilution hemodiafiltration displays no hemodynamic advantage over low-flux hemodialysis under matched conditions.

Nikolaos Karamperis1, Erik Sloth, Jens Dam Jensen.   

Abstract

BACKGROUND: It is the prevailing view that convective dialysis techniques stabilize blood pressure. The aim of this study was to compare the intrasession hemodynamics during high-dose predilution hemodiafiltration (HDF) and low-flux hemodialsis, under strict controlled conditions.
METHODS: Twelve stable hemodialysis patients were investigated in a randomized crossover blinded controlled trial. The patients were allocated to one session of predilution HDF (substitution fluid 1.20 +/- 0.10 L/kg body weight) and one session of hemodialysis at 4(1/2) hours. To eliminate confounding factors, dialysis dose, ultrafiltration volume and arterial temperature were matched. At the start of the dialysis the patients' core temperature was "locked" by an automatic feedback system regulating the dialysate temperature; thereby, patients' temperature was kept stable throughout the whole treatment. The calcium-ion concentration in the substitution/dialysis fluid was 1.25 mmol/L. Cardiac output was measured hourly by the ultrasound velocity dilution method.
RESULTS: Mean blood pressure, cardiac output, stroke volume, cardiac work, and relative blood volume was significantly reduced in both treatments. Total peripheral resistance increased significantly in both groups. Ultrafiltration volume, cardiopulmonary recirculation, Kt/V, and total energy transfer were similar for hemodialysis and HDF. The pulse rate showed no significant change throughout both sessions. No significant differences were revealed between hemodialysis and HDF.
CONCLUSION: The hemodynamics of predilution HDF and low-flux hemodialysis displayed a similar profile during matched conditions. An acute circulatory benefit of convective solute removal over diffusive could not be demonstrated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780117     DOI: 10.1111/j.1523-1755.2005.00242.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Intradialytic Cardiac Magnetic Resonance Imaging to Assess Cardiovascular Responses in a Short-Term Trial of Hemodiafiltration and Hemodialysis.

Authors:  Charlotte Buchanan; Azharuddin Mohammed; Eleanor Cox; Katrin Köhler; Bernard Canaud; Maarten W Taal; Nicholas M Selby; Susan Francis; Chris W McIntyre
Journal:  J Am Soc Nephrol       Date:  2016-11-10       Impact factor: 10.121

2.  Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis.

Authors:  Enric Vilar; Andrew C Fry; David Wellsted; James E Tattersall; Roger N Greenwood; Ken Farrington
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-09       Impact factor: 8.237

3.  Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled One-Year Intervention Trial (the SAFIR Study).

Authors:  Christian Daugaard Peters; Krista Dybtved Kjaergaard; Jens Dam Jensen; Kent Lodberg Christensen; Charlotte Strandhave; Ida Noerager Tietze; Marija Kristina Novosel; Bo Martin Bibby; Bente Jespersen
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

4.  Online-haemodiafiltration vs. conventional haemodialysis: a cross-over study.

Authors:  Guillaume Jean; Jean-Marc Hurot; Patrik Deleaval; Brice Mayor; Christie Lorriaux
Journal:  BMC Nephrol       Date:  2015-05-09       Impact factor: 2.388

5.  A Randomized, Single-Blind, Crossover Trial of Recovery Time in High-Flux Hemodialysis and Hemodiafiltration.

Authors:  James R Smith; Norica Zimmer; Elizabeth Bell; Bernard G Francq; Alex McConnachie; Robert Mactier
Journal:  Am J Kidney Dis       Date:  2016-12-23       Impact factor: 8.860

6.  Changes in cardiac output with hemodialysis relate to net volume balance and to inferior vena cava ultrasound collapsibility in critically ill patients.

Authors:  Matthew J Kaptein; John S Kaptein; Christopher D Nguyen; Zayar Oo; Phyu Phyu Thwe; Myint Bo Thu; Elaine M Kaptein
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.